Phase I trial of irinotecan, infusional 5-fluorouracil, and leucovorin (FOLFIRI) with erlotinib (OSI-774): early termination due to increased toxicities (Q45099310)
Jump to navigation
Jump to search
scientific article published in October 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I trial of irinotecan, infusional 5-fluorouracil, and leucovorin (FOLFIRI) with erlotinib (OSI-774): early termination due to increased toxicities |
scientific article published in October 2004 |
Statements
1 reference
Phase I trial of irinotecan, infusional 5-fluorouracil, and leucovorin (FOLFIRI) with erlotinib (OSI-774): early termination due to increased toxicities (English)
1 reference
1 reference
Wells A Messersmith
1 reference
Daniel A Laheru
1 reference
Neil N Senzer
1 reference
Ross C Donehower
1 reference
Paula Grouleff
1 reference
Theresa Rogers
1 reference
Sean K Kelley
1 reference
David A Ramies
1 reference
Bert L Lum
1 reference
1 October 2004
1 reference
1 reference
Identifiers
1 reference